But the drug’s promise as a treatment for the virus is in serious doubt after the Elgazzar study was pulled from the Research Square website on Thursday “due to ethical concerns”. “According to the original data, the number was 0, the same as the ivermectin treatment group. In the UK, the University of Oxford is testing whether giving people with Covid-19 ivermectin prevents them ending up in hospital. This was concerning because two meta-analyses of ivermectin for treating Covid-19 had included the Elgazzar study in the results. “If you remove this one study from the scientific literature, suddenly there are very few positive randomised control trials of ivermectin for Covid-19.

Source: The Guardian July 15, 2021 17:26 UTC